Redox signaling is an early event in the pathogenesis of renovascular hypertension

International Journal of Molecular Sciences

Volumn 14, Issue 9, 2013, Pages 18640-18656

  Hartono, Stella P ^a,b   Knudsen, Bruce E ^b   Zubair, Adeel S ^a   Nath, Karl A ^b   Textor, Stephen J ^b   Lerman, Lilach O ^b   Grande, Joseph P ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Inflammation; Oxidative stress; Renin angiotensin aldosterone system; Renovascular hypertension

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; HISTOPATHOLOGY; INFLAMMATORY CELL; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY PARENCHYMA; MACROPHAGE; MALE; MOUSE; NEPHRITIS; NONHUMAN; ONSET AGE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOGENESIS; PLASMA RENIN ACTIVITY; RENAL ARTERY; RENOVASCULAR HYPERTENSION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; HYPERTENSION, RENOVASCULAR; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 84884183310     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140918640     Document Type: Article

References (38)

1. Hansen, K.J.; Edwards, M.S.; Craven, T.E.; Cherr, G.S.; Jackson, S.A.; Appel, R.G.; Burke, G.L.; Dean, R.H. Prevalence of renovascular disease in the elderly: A population-based study. J. Vasc. Surg. 2002, 36, 443-451.
2. Fava, C.; Minuz, P.; Patrignani, P.; Morganti, A. Renal artery stenosis and accelerated atherosclerosis: Which comes first? J. Hypertens. 2006, 24, 1687-1696.
3. Kalra, P.A.; Guo, H.; Kausz, A.T.; Gilbertson, D.T.; Liu, J.; Chen, S.C.; Ishani, A.; Collins, A.J.; Foley, R.N. Atherosclerotic renovascular disease in United States patients aged 67 years or older: Risk factors, revascularization, and prognosis. Kidney Int. 2005, 68, 293-301.
4. Conlon, P.J.; Athirakul, K.; Kovalik, E.; Schwab, S.J.; Crowley, J.; Stack, R.; McCants, C.B., Jr.; Mark, D.B.; Bashore, T.M.; Albers, F. Survival in renal vascular disease. J. Am. Soc. Nephrol. 1998, 9, 252-256.
5. Conlon, P.J.; Little, M.A.; Pieper, K.; Mark, D.B. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001, 60, 1490-1497.
6. Textor, S.C. Managing renal arterial disease and hypertension. Curr. Opin. Cardiol. 2003, 18, 260-267.
7. Textor, S.C.; Wilcox, C.S. Renal artery stenosis: A common, treatable cause of renal failure? Annu. Rev. Med. 2001, 52, 421-442.
8. Textor, S.C. Ischemic nephropathy: Where are we now? J. Am. Soc. Nephrol. 2004, 15, 1974-1982.
9. Wheatley, K.; Ives, N.; Gray, R.; Kalra, P.A.; Moss, J.G.; Baigent, C.; Carr, S.; Chalmers, N.; Eadington, D.; Hamilton, G. et al. Revascularization versus medical therapy for renal-artery stenosis. N. Engl. J. Med. 2009, 361, 1953-1962.
10. Warner, G.M.; Cheng, J.; Knudsen, B.E.; Gray, C.E.; Deibel, A.; Juskewitch, J.E.; Lerman, L.O.; Textor, S.C.; Nath, K.A.; Grande, J.P. Genetic deficiency of Smad3 protects the kidneys from atrophy and interstitial fibrosis in 2K1C hypertension. Am. J. Physiol. Ren. Physiol. 2012, 302, F1455-F1464.
11. Cheng, J.; Zhou, W.; Warner, G.M.; Knudsen, B.E.; Garovic, V.D.; Gray, C.E.; Lerman, L.O.; Platt, J.L.; Romero, J.C.; Textor, S.C. et al. Temporal analysis of signaling pathways activated in a murine model of 2-kidney, 1-clip hypertension. Am. J. Physiol. Ren. Physiol. 2009, 297, F1055-F1068.
12. Wang, D.; Warner, G.M.; Yin, P.; Knudsen, B.E.; Cheng, J.; Butters, K.A.; Lien, K.R.; Gray, C.E.; Garovic, V.D.; Lerman, L.O. et al. Grande, Inhibition of p38 MAPK attenuates renal atrophy and fibrosis in a murine renal artery stenosis model. Am. J. Physiol. Ren. Physiol. 2013, 304, F938-F947.
13. Edwards, M.; Craven, T.; Burke, G.; Dean, R.; Hansen, K. Renovascular disease and the risk of adverse coronary events in the elderly: A prospective, population-based study. Arch. Intern. Med. 2005, 165, 207-213.
14. Favreau, F.; Zhu, X.-Y.; Krier, J.D.; Lin, J.; Warner, L.; Textor, S.C.; Lerman, L.O. Revascularization of swine renal artery stenosis improves renal function but not the changes in vascular structure. Kidney Int. 2010, 78, 1110-1118.
15. Eirin, A.; Zhu, X.Y.; Urbieta-Caceres, V.H.; Grande, J.P.; Lerman, A.; Textor, S.C.; Lerman, L.O. Persistent kidney dysfunction in swine renal artery stenosis correlates with outer cortical microvascular remodeling. Am. J. Physiol. Ren. Physiol. 2011, 300, F1394-F1401.
16. Chade, A.R.; Rodriguez-Porcel, M.; Grande, J.P.; Krier, J.D.; Lerman, A.; Romero, J.C.; Napoli, C.; Lerman, L.O. Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 2002, 106, 1165-1171.
17. Eirin, A.; Zhu, X.Y.; Li, Z.; Ebrahimi, B.; Zhang, X.; Tang, H.; Korsmo, M.J.; Chade, A.R.; Grande, J.P.; Ward, C.J. et al. Endothelial outgrowth cells shift macrophage phenotype and improve kidney viability in swine renal artery stenosis. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 1006-1013.
18. Lavoie, J.L.; Sigmund, C.D. Minireview: Overview of the renin-angiotensin system-An endocrine and paracrine system. Endocrinology 2003, 144, 2179-2183.
19. Bader, M.; Peters, J.; Baltatu, O.; Müller, D.; Luft, F.; Ganten, D. Tissue renin-angiotensin systems: New insights from experimental animal models in hypertension research. J. Mol. Med. (Berl. Ger.) 2001, 79, 76-102.
20. Rohrwasser, A.; Morgan, T.; Dillon, H.; Zhao, L.; Callaway, C.; Hillas, E.; Zhang, S.; Cheng, T.; Inagami, T.; Ward, K. et al. Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension 1999, 34, 1265-1274.
21. Chade, A.R.; Rodriguez-Porcel, M.; Grande, J.P.; Zhu, X.Y.; Sica, V.; Napoli, C.; Sawamura, T.; Textor, S.C.; Lerman, A.; Lerman, L.O. Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 1295-1301.
22. Chade, A.R.; Rodriguez-Porcel, M.; Herrmann, J.; Krier, J.D.; Zhu, X.; Lerman, A.; Lerman, L.O. Beneficial effects of antioxidant vitamins on the stenotic kidney. Hypertension 2003, 42, 605-612.
23. Rajagopalan, S.; Kurz, S.; Munzel, T.; Tarpey, M.; Freeman, B.A.; Griendling, K.K.; Harrison, D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Investig. 1996, 97, 1916-1923.
24. Chabrashvili, T.; Tojo, A.; Onozato, M.L.; Kitiyakara, C.; Quinn, M.T.; Fujita, T.; Welch, W.J.; Wilcox, C.S. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 2002, 39, 269-274.
25. Tojo, A.; Onozato, M.L.; Kobayashi, N.; Goto, A.; Matsuoka, H.; Fujita, T. Angiotensin II and oxidative stress in Dahl Salt-sensitive rat with heart failure. Hypertension 2002, 40, 834-839.
26. Liu, G.; Fang, F.; Zhou, J.; Koulajian, K.; Yang, S.; Lam, L.; Reich, H.; John, R.; Herzenberg, A.; Giacca, A. et al. Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse. Diabetologia 2012, 55, 2522-2532.
27. Geiszt, M.; Kopp, J.B.; Varnai, P.; Leto, T.L. Identification of Renox, an NAD(P)H oxidase in kidney. Proc. Natl. Acad. Sci. USA 2000, 97, 8010-8014.
28. Chabrashvili, T.; Kitiyakara, C.; Blau, J.; Karber, A.; Aslam, S.; Welch, W.J.; Wilcox, C.S. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285, R117-R124.
29. Lassegue, B.; Sorescu, D.; Szocs, K.; Yin, Q.Q.; Akers, M.; Zhang, Y.; Grant, S.L.; Lambeth, J.D.; Griendling, K.K. Novel gp91(phox) homologues in vascular smooth muscle cells-Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 2001, 88, 888-894.
30. Nlandu Khodo, S.; Dizin, E.; Sossauer, G.; Szanto, I.; Martin, P.-Y.; Feraille, E.; Krause, K.H.; de Seigneux, S. NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury. J. Am. Soc. Nephrol. 2012, 23, 1967-1976.
31. Babelova, A.; Avaniadi, D.; Jung, O.; Fork, C.; Beckmann, J.; Kosowski, J.; Weissmann, N.; Anilkumar, N.; Shah, A.M.; Schaefer, L. et al. Role of Nox4 in murine models of kidney disease. Free Radic. Biol. Med. 2012, 53, 842-853.
32. Vaziri, N.D.; Dicus, M.; Ho, N.D.; Boroujerdi-Rad, L.; Sindhu, R.K. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int. 2003, 63, 179-185.
33. Lerman, L.O.; Nath, K.A.; Rodriguez-Porcel, M.; Krier, J.D.; Schwartz, R.S.; Napoli, C.; Romero, J.C. Increased oxidative stress in experimental renovascular hypertension. Hypertension 2001, 37, 541-546.
34. Chade, A.R.; Rodriguez-Porcel, M.; Herrmann, J.; Zhu, X.Y.; Grande, J.P.; Napoli, C.; Lerman, A.; Lerman, L.O. Antioxidant intervention blunts renal injury in experimental renovascular disease. J. Am. Soc. Nephrol. 2004, 15, 958-966.
35. Adler, S.; Huang, H. Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase. Am. J. Physiol. Ren. Physiol. 2004, 287, F907-F913.
36. Zhao, W.; Chen, S.S.; Chen, Y.; Ahokas, R.A.; Sun, Y. Kidney fibrosis in hypertensive rats: Role of oxidative stress. Am. J. Nephrol. 2008, 28, 548-554.
37. Vielhauer, V.; Anders, H.J.; Perez de Lema, G.; Luckow, B.; Schlondorff, D.; Mack, M. Phenotyping renal leukocyte subsets by four-color flow cytometry: Characterization of chemokine receptor expression. Nephron Exp. Nephrol. 2003, 93, e63.
38. Zhang, X.; Urbieta-Caceres, V.H.; Eirin, A.; Bell, C.C.; Crane, J.A.; Tang, H.; Jordan, K.L.; Oh, Y.K.; Zhu, X.Y.; Korsmo, M.J. et al. Humanin prevents intra-renal microvascular remodeling and inflammation in hypercholesterolemic ApoE deficient mice. Life Sci. 2012, 91, 199-206.